Draisma, G.

cancer screening model breast prostate prostate cancer mortality women study incidence trial breast cancer mammography stage estimate group population treatment detection overdiagnosi result death number screen survival table breast cancer mortality diagnosis effect interval breast cancer screening psa screening disease reduction sensitivity mammography screening state erspc breast cancers health netherland history parameter breast cancer deaths control rotterdam difference distribution tumor breast cancer incidence referral patient miscan period biopsy symptom radiation european randomized study reading absence screen-detected benefit therapy mammogram 100 000 women cancer institute gleason research diameter tumour increase screen-detected cancers score european control group examination overdetection level journal analysis